Schonfeld Strategic Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-100,120
Closed -$711K 940
2017
Q3
$711K Buy
+100,120
New +$711K 0.06% 327